Article
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) - 1 Mar 2014
Kim Min Hwan, Shim Hyo Sup, Kang Dae Ryong, Jung Ji Ye, Lee Chang Young, Kim Dae Joon, Lee Jin Gu, Bae Mi Kyung, Kim Hye Ryun, Lim Sun Min, Kim Eun Young, Park Ji Soo, Chung Kyung Young, Kim Hyun-Jung, Kim Joo Hang, Cho Byoung Chul
Abstract excerpt
OBJECTIVES: The aim of this study is to evaluate the prevalence and prognostic significance of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) rearrangement in never-smokers with surgically resected lung adenocarcinoma. METHODS: We retrospectively analyzed 162 consecutive never-smokers who underwent curative resection for stage IB to IIIA lung adenocarcinoma at a single institution. We concurrently...
Topics
- Adenocarcinoma
- Anaplastic Lymphoma Kinase
- DNA Mutational Analysis
- ErbB Receptors
- Gene Rearrangement
- Lung Neoplasms
- Mutation
- Neoplasm Staging
- Pneumonectomy
